Johnson & Johnson News

The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.

Sheri S. McCoy, the chief executive officer and a director of Avon Products, will deliver the keynote address at Stonehill College's 62nd Commencement on Sunday, May 19.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson and Johnson could be sourcing commercial quantities of poppies outside Tasmania in 2015.

Research by media monitoring company Precise, published in March 2013 says that consumers are more likely to view FMCG companies favourably if they develop a recognisable corporate brand.

Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.

With interest rates near zero, investors have been desperately seeking yield. As a result, one of the hottest trades for investors over the last three to four years has been buying large companies that pay high dividends.

In Part I of "Johnson & Johnson: At The Crossroads", consideration was given to whether a dividend growth rate of 8.2% was sustainable if net income growth rate remained around the projected 6%. It was determined that this gap between dividend and net income growth rates was likely sustainable for at least the next 15 years.

When shopping in any store that carries national brands, it's virtually impossible to remember which ones you're not supposed to buy for which reasons.

Johnson & Johnson won U.S. approval to use its rheumatoid arthritis drug Simponi to treat patients suffering from a moderate to severe inflammatory bowel disease.

Assessing whether a stock is a "value play" or a "value trap" has become a popular hobby for financial writers.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! In one of the more curious departures of a high-ranking FDA official, Leona Brenner-Gati unexpectedly resigned from the agency earlier this month and did so immediately for unexplained personal reasons.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson & Johnson unit Janssen Research and Development LLC said the U.S. Food and Drug Administration has granted priority review to its new drug application for simeprevir, its investigational treatment of genotype 1 chronic hepatitis C in adult patients ... (more)

In this article, I'm going to show how much Johnson & Johnson stock is worth according to a Warren Buffett "owner earnings" style analysis.

I'm not quite as fanatical as Warren, but I do enjoy digging into a company's annual report to learn something new.

A view shows the U.S. Food and Drug Administration logo at the lobby of its headquarters in Silver Spring, Maryland August 14, 2012.

It is putting in $30 million in a Band-Aid type ad campaign. This is the first time in a decade and its first global one ever that the company is indulging in a corporate re-brand ad campaign following recall of " millions of bottles and packages of Tylenol, Benadryl, Motrin and other over-the-counter medicines.

Today, Governor Rick Scott kicked off the Building Up Florida Manufacturing Victory Tour celebrating the elimination of the sales tax on manufacturing equipment, at Johnson and Johnson in Jacksonville.

Federal regulators have granted priority review for Janssen Research & Development's experimental treatment for hepatitis C, a contagious liver disease that affects more than 3 million people in the United States.

Patent expiration is one of the number one reasons for pharma companies' revenue deterioration.

If there was ever a stock that defined the buy and hold investment strategy it is Johnson & Johnson .